Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 4
2013 3
2014 3
2015 2
2016 3
2017 7
2018 3
2019 5
2020 9
2021 7
2022 8
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
The Present and Future of Optic Pathway Glioma Therapy.
Dal Bello S, Martinuzzi D, Tereshko Y, Veritti D, Sarao V, Gigli GL, Lanzetta P, Valente M. Dal Bello S, et al. Among authors: sarao v. Cells. 2023 Sep 29;12(19):2380. doi: 10.3390/cells12192380. Cells. 2023. PMID: 37830595 Free PMC article. Review.
Fundamental principles of an effective diabetic retinopathy screening program.
Lanzetta P, Sarao V, Scanlon PH, Barratt J, Porta M, Bandello F, Loewenstein A; Vision Academy. Lanzetta P, et al. Among authors: sarao v. Acta Diabetol. 2020 Jul;57(7):785-798. doi: 10.1007/s00592-020-01506-8. Epub 2020 Mar 28. Acta Diabetol. 2020. PMID: 32222818 Free PMC article. Review.
Neovascular age-related macular degeneration.
Veritti D, Sarao V, Lanzetta P. Veritti D, et al. Among authors: sarao v. Ophthalmologica. 2012;227 Suppl 1:11-20. doi: 10.1159/000337154. Epub 2012 Apr 24. Ophthalmologica. 2012. PMID: 22517121 Review.
Validation of Esaso Classification of Diabetic Maculopathy.
Panozzo G, Franzolin E, Giannarelli D, Dalla Mura G, Longo R, Cicinelli MV; ESASO Study Group. Panozzo G, et al. Eur J Ophthalmol. 2024 Mar;34(2):497-501. doi: 10.1177/11206721231186649. Epub 2023 Jul 16. Eur J Ophthalmol. 2024. PMID: 37455446
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey).
Sharma A, Holz FG, Regillo CD, Freund KB, Sarraf D, Khanani AM, Baumal C, Holekamp N, Tadayoni R, Kumar N, Parachuri N, Kuppermann BD; International Retina Biosimilar Study Group (Inter BIOS Group); International Retina Biosimilar Study Group (Inter BIOS Group); Bandello F, Querques G, Loewenstein A, Özdek Ş, Rezai K, Laurent K, Bilgic A, Lanzetta P, Zur D, Yannuzzi N, Corradetti G, Kaiser P, Hilely A, Boyer D, Rachitskaya A, Chakravarthy U, Wintergerst M, Sarao V, Parolini B, Mruthyunjaya P, Nguyen QD, Do D, Keane PA, Hassan T, Sridhar J, Eichenbaum D, Grewal D, Splitzer M. Sharma A, et al. Among authors: sarao v. Expert Opin Biol Ther. 2023 Jul-Dec;23(8):851-859. doi: 10.1080/14712598.2023.2176218. Epub 2023 Feb 19. Expert Opin Biol Ther. 2023. PMID: 36726203
Pharmacotherapy for treatment of retinal vein occlusion.
Sarao V, Bertoli F, Veritti D, Lanzetta P. Sarao V, et al. Expert Opin Pharmacother. 2014 Nov;15(16):2373-84. doi: 10.1517/14656566.2014.956083. Epub 2014 Sep 5. Expert Opin Pharmacother. 2014. PMID: 25190137 Review.
Fluocinolone acetonide for the treatment of diabetic macular edema.
Veritti D, Sarao V, Diplotti L, Samassa F, Lanzetta P. Veritti D, et al. Among authors: sarao v. Expert Opin Pharmacother. 2017 Oct;18(14):1507-1516. doi: 10.1080/14656566.2017.1363182. Epub 2017 Aug 9. Expert Opin Pharmacother. 2017. PMID: 28764565 Review.
Author’s response.
Sarao V, Bertoli F, Veritti D, Lanzetta P. Sarao V, et al. Expert Opin Pharmacother. 2015 Feb;16(3):448. Expert Opin Pharmacother. 2015. PMID: 25741543 No abstract available.
52 results